| scholarly article | Q13442814 |
| P50 | author | Robert Moulder | Q41535006 |
| Bengt Långström | Q5969279 | ||
| P2093 | author name string | Orvar Eeg-Olofsson | |
| Yasuyoshi Watanabe | |||
| Torsten Danfors | |||
| Per Hartvig | |||
| Anne-Liis von Knorring | |||
| Bo Stromberg | |||
| Richard Torstenson | |||
| Ulrika Wester | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism | Q38404 |
| placebo | Q269829 | ||
| sapropterin | Q419808 | ||
| P304 | page(s) | 485-489 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Journal of Clinical Psychopharmacology | Q6294969 |
| P1476 | title | Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study | |
| P478 | volume | 25 |
| Q34003529 | Central tetrahydrobiopterin concentration in neurodevelopmental disorders |
| Q60946889 | Comparison of Three Clinical Trial Treatments for Autism Spectrum Disorder Through Multivariate Analysis of Changes in Metabolic Profiles and Adaptive Behavior |
| Q28082433 | Complementary and Alternative Therapies for Autism Spectrum Disorder |
| Q37622166 | Developmental susceptibility of neurons to transient tetrahydrobiopterin insufficiency and antenatal hypoxia-ischemia in fetal rabbits |
| Q37442629 | Examination of tetrahydrobiopterin pathway genes in autism |
| Q26744037 | Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes |
| Q47564469 | Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment? |
| Q36764473 | Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study |
| Q58780865 | Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents |
| Q92854992 | Speech-Stimulating Substances in Autism Spectrum Disorders |
| Q36399716 | TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME |
| Q34126874 | Tetrahydrobiopterin as a novel therapeutic intervention for autism |
| Q47551499 | The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder |
| Q37410883 | The effects of tetrahydrobiopterin (BH4) treatment on brain function in individuals with phenylketonuria. |
| Q37246581 | The role of nutraceuticals in the management of autism |
| Q28239931 | The status of pharmacotherapy for autism spectrum disorders |
| Q33814205 | Treatments for biomedical abnormalities associated with autism spectrum disorder. |
Search more.